Propranolol
|
40-240 mg
|
Frequent: asthenia, poor tolerance to effort
|
Asthma, heart failure, atrio-ventricular block, bradycardia
|
Metoprolol
|
100-200 mg
|
Timolol (without MA)
|
10-20 mg
|
Atenolol (without MA)
|
100 mg
|
Rare: insomnia, nightmares, impotence, depression
|
NB: possibility of aggravation of migraines with aura
|
Nadolol (without MA)
|
80-240 mg
|
Nebivolol (without MA)
|
5 mg
|
Oxetorone
|
60-180 mg (1–3 tablets) as one dose in the evening
|
Frequent: somnolence
|
|
Rare: diarrhoea necessitating discontinuation of treatment
|
Amitriptyline
|
10-50 mg in the evening
|
Dry mouth, somnolence
|
Glaucoma, prostatic adenoma
|
Weight gain
|
Pizotifen
|
3 tablets per day at progressive doses
|
Sedation
|
Glaucoma, uredo-prostatic problems
|
Weight gain
|
Rare: digestive problems, dizziness, muscular pain, asthenia
|
Topiramate
|
50-100 mg
|
Paresthesia
|
Hypersensitivity to topiramate
|
Weight loss
|
Pregnancy
|
Cognitive effects (word-finding difficulties)
|
|
Rare: renal calculi, acute myopia associated with secondary angle closure glaucoma
|
Sodium valproate (without MA)
|
500-1000 mg
|
Nausea, weight gain, somnolence, trembling, alopecia, liver attack
|
Liver diseases
|
Pregnancy
|
Methysergide
|
2-6 mg (1–3 tablets) Necessary to stop treatment for 1 month every 6 months
|
Frequent: nausea, dizziness, insomnia
|
Hypertension, heart failure, arteriopathologies, gastric ulcer, liver and kidney failure, association with triptans
|
Rare: retroperitoneal fibrosis
|
Flunarizine
|
10 mg (1 tablet in the evening). Not for more than 6 consecutive months
|
Frequent: somnolence, weight gain
|
Depressive syndrome, extra-pyramidal syndrome
|
Rare: depression, extrapyramidal syndrome
|
Gabapentin (without MA)
|
1200-2400 mg
|
Nausea, vomiting, convulsions, somnolence, ataxia, dizziness
|
Hypersensitivity to gabapentin
|
Dihydroergotamine
|
10 mg
|
Nausea
|
Association with triptans
|
Indoramin
|
50 mg
|
Somnolence, nasal congestion, dry mouth, ejaculation problems
|
Hypersensitivity to one of the components of the drug product, Parkinson’s disease, severe heart, liver and kidney failure
|
Candesartan (without MA)
|
8-16 mg
|
Arterial hypotension, dizziness
|
Hypersensitivity, severe liver and kidney failure
|
2nd and 3rd trimester of pregnancy
|
Venlafaxin (without MA) |
75-150 mg |
Nausea, dizziness, hypersudation, somnolence, nervousness, dry mouth |
Hypersensitivity to venlafaxine, association with non-selective MAOI, congenital galactosaemia, breast feeding |